Free Trial

C4 Therapeutics (CCCC) Insider Trading & Ownership

C4 Therapeutics logo
$6.04 +0.07 (+1.17%)
(As of 11/7/2024 ET)

C4 Therapeutics (NASDAQ:CCCC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.55%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$115,735.20
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$53,121.80
Get CCCC Insider Trade Alerts

Want to know when executives and insiders are buying or selling C4 Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CCCC Insider Buying and Selling by Quarter

C4 Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/8/2023Utpal KoppikarDirectorBuy5,667$5.60$31,735.20  
4/12/2022Andrew HirschCEOBuy10,000$8.40$84,000.00  
12/17/2021Malcolm SalterDirectorSell755$30.25$22,838.75  
11/19/2021Malcolm SalterDirectorSell755$40.11$30,283.05  
(Data available from 1/1/2013 forward)

CCCC Insider Trading Activity - Frequently Asked Questions

The list of insiders at C4 Therapeutics includes Andrew Hirsch, Malcolm Salter, and Utpal Koppikar. Learn more on insiders at CCCC.

8.55% of C4 Therapeutics stock is owned by insiders. Learn more on CCCC's insider holdings.

The following insider purchased CCCC shares in the last 24 months: Utpal Koppikar ($31,735.20).

Insiders have purchased a total of 5,667 CCCC shares in the last 24 months for a total of $31,735.20 bought.

C4 Therapeutics Key Executives

  • Mr. Andrew J. Hirsch M.B.A. (Age 53)
    CEO, President & Director
    Compensation: $971k
  • Dr. Kenneth C. Anderson M.D. (Age 73)
    Ph.D., Co-Founder, Independent Director & Member of Scientific Advisory Board
    Compensation: $39.03k
  • Dr. Stewart FisherDr. Stewart Fisher (Age 57)
    Chief Scientific Officer
    Compensation: $657.34k
  • Mr. Scott N. Boyle M.B.A. (Age 46)
    Ph.D., Chief Business Officer
    Compensation: $672.78k
  • Dr. Nathanael S. Gray Ph.D.
    Co-Founder & Member of Scientific Advisory Board
  • Ms. Kendra Adams
    Chief Financial Officer
  • Mr. Mark Mossler (Age 51)
    Chief Accounting Officer
  • Ms. Jolie M. Siegel J.D. (Age 47)
    Chief Legal Officer & Corporate Secretary
    Compensation: $610.4k
  • Ms. Kelly A. Schick (Age 44)
    Chief People Officer
  • Dr. Isabel Chiu Ph.D.
    Senior Vice President of Strategic Alliances & Business Development


This page (NASDAQ:CCCC) was last updated on 11/8/2024 by MarketBeat.com Staff
From Our Partners